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Summary
Continuous passive motion (CPM) is currently a part of patient rehabilitation regimens after a variety of orthopedic surgical procedures. While
CPM can enhance the joint healing process, the direct effects of CPM on cartilage metabolism remain unknown. Recent in vivo and in vitro
observations suggest that mechanical stimuli can regulate articular cartilage metabolism of proteoglycan 4 (PRG4), a putative lubricating and
chondroprotective molecule found in synovial ﬂuid and at the articular cartilage surface.
Objectives: (1) Determine the topographical variation in intrinsic cartilage PRG4 secretion. (2) Apply a CPM device to whole joints in biore-
actors and assess effects of CPM on PRG4 biosynthesis.
Methods: A bioreactor was developed to apply CPM to bovine stiﬂe joints in vitro. Effects of 24 h of CPM on PRG4 biosynthesis were
determined.
Results: PRG4 secretion rate varied markedly over the joint surface. Rehabilitative joint motion applied in the form of CPM regulated PRG4
biosynthesis, in a manner dependent on the duty cycle of cartilage sliding against opposing tissues. Speciﬁcally, in certain regions of the
femoral condyle that were continuously or intermittently sliding against meniscus and tibial cartilage during CPM, chondrocyte PRG4 synthesis
was higher with CPM than without.
Conclusions: Rehabilitative joint motion, applied in the form of CPM, stimulates chondrocyte PRG4 metabolism. The stimulation of PRG4
synthesis is one mechanism by which CPM may beneﬁt cartilage and joint health in post-operative rehabilitation.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





Articular cartilage functions to provide a low-friction, load-
bearing surface which allows the bones of diarthrodial joints
to slide smoothly against each other while transmitting load.
Cartilage tissue has classically been divided into three
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Received 25 July 2006; revision accepted 29 October 2006.56zones: superﬁcial, middle, and deep, with distinct biochem-
ical content and organization that impart speciﬁc functions
to each zone. For example, chondrocytes of the superﬁcial
zone of cartilage secrete specialized molecules, encoded
by the proteoglycan 4 gene (PRG4, GenBank Accession
Numbers: AF056218 for bovine partial sequence, U70136
for complete human sequence, also termed lubricin, SZP,
CACP)1e3, that are not expressed by chondrocytes in the
deeper zone1. These PRG4 molecules mediate, at least
in part, the boundary lubrication function of the articular
cartilage superﬁcial zone4e7, and have been suggested to
protect the cartilage surface by preventing cellular adhesion
to the surface2. Mutations in the PRG4 gene cause campto-
dactylyearthropathyecoxa varaepericarditis (CACP) dis-
ease, which results in early onset non-inﬂammatory joint
failure8e10, demonstrating the functional importance of the
gene in vivo.6
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sis that mechanical stimuli play a role in regulating PRG4
expression in articular cartilage in vivo. During embryonic
development of the mouse elbow joint, PRG4 mRNA ex-
pression begins at the onset of joint cavitation10, suggesting
that PRG4 expression might be induced by the initiation of
relative motion between the articular surfaces. A similar pat-
tern is seen during post-natal growth, where fetal bovine
cartilage exhibits inconsistent PRG4 expression by chon-
drocytes near the articular surface, in contrast with adult
tissue, which has abundant PRG4-expressing cells near
the surface11. In both cases (in utero and in vivo), increased
chondrocyte expression of PRG4 coincides with increased
joint motion. Furthermore, abnormal mechanical stimuli
may result in decreased PRG4 expression. In a meniscec-
tomy-induced (i.e., mechanically induced) osteoarthritis
model in sheep, abnormal joint motion resulted in degener-
ation of articular cartilage in certain regions of the tibial
plateau, with decreased PRG4 expression in these re-
gions12. PRG4 expression was also higher in covered (by
meniscus) than uncovered regions for tibial plateaus of nor-
mal ovine joints, suggesting that site-associated variations
in intrinsic PRG4 expression could be due to mechanical
factors as well12.
Other studies have demonstrated that certain mechanical
stimuli can regulate PRG4 metabolism by chondrocytes
cultured in various conﬁgurations in vitro. Dynamic surface
motion applied to chondrocytes embedded in polyurethane
constructs13, and cyclic tensile strain applied to chondro-
cytes in alginate constructs14 resulted in increased PRG4
mRNA expression. Similarly, certain magnitudes of static
and dynamic compression15 and dynamic tissue shear16
applied to cartilage explants altered PRG4 proteoglycan se-
cretion relative to that of unloaded controls, both during
loading and following unloading. Such in vitro studies allow
the application of well-deﬁned mechanical stimuli under
controlled biochemical environments by eliminating a variety
of systemic factors present in vivo that affect chondrocyte
metabolism. However, even in cylindrical cartilage explants,
where chondrocytes are still embedded in their native ma-
trix, the micro-environmental phenomena (ﬂuid ﬂow, cell
and matrix deformation) resulting from in vitro mechanical
loading may be quite different from those experienced by
intact articular cartilage in its native conﬁguration covering
bones, under physiological joint motion.
Continuous passive motion (CPM) was originally pro-
posed as a therapeutic alternative to the traditional rehabil-
itative practice of joint immobilization for many orthopedic
disorders and injuries17. CPM stimulation utilizes an exter-
nal motorized device to move joints passively through
a speciﬁed range of motion18. CPM is currently applied
post-operatively to enhance patient recovery after anterior
cruciate ligament reconstruction19,20. CPM was also found
in experimental studies to promote healing of articular carti-
lage defects17,21, and a variety of other joint afﬂictions22,
supporting its use in post-operative rehabilitation of carti-
lage defect repair by autologous chondrocyte implanta-
tion23,24 and microfracture25. However, the direct effects
of CPM on chondrocyte metabolism remain unknown.
The hypothesis tested here was that a CPM device could
be used to stimulate a whole joint during culture, and that
this rehabilitative motion, applied to cartilage in its native
conﬁguration, regulates chondrocyte metabolism. The
objectives of this study were to (1) determine the spatial var-
iation in intrinsic cartilage PRG4 secretion before bioreactor
joint culture, and (2) determine effects of CPM on PRG4
biosynthesis using a bioreactor for culture of whole joints.Methods
JOINT ISOLATION
Immature (1e3 weeks) bovine stiﬂe joints were obtained
from an abattoir. Soft tissues were cleared away with a scal-
pel, and the femur and tibia bones were cut with a bone saw
such that the total length of the extended joint wasw25 cm.
The contents of the bone marrow cavity were removed with
a curette and the cavity was washed three times with 3%
hydrogen peroxide. The outside of the joint was then
scrubbed with 3% hydrogen peroxide and patted dry with
gauze pads. The following steps were performed using
aseptic technique, and all materials used, including dissec-
tion surface, were initially sterile. The joint was scrubbed
with sponges soaked with 7.5% povidoneeiodine solution,
and patted dry again. Under continuous irrigation with phos-
phate buffered saline (PBS) with penicillinestreptomycine
fungizone, some joint tissues (muscle, periosteum, patella,
patellar tendon, synovium, and fat) were cleared away us-
ing surgical scissors, a scalpel, and a periosteal elevator,
taking care to leave the joint capsule intact until the end
of this procedure, at which point it was opened and re-
moved. The joint tissues remaining for bioreactor culture
were the femoral and tibial bones and associated articular
cartilage, the ligaments necessary to provide joint stability
(anterior and posterior cruciate, lateral and medial collat-
eral), and lateral and medial menisci.
BIOREACTOR CULTURE OF WHOLE JOINTS
AND CPM STIMULATION (FIG. 1)
The cut ends of the bones were secured into custom
designed polysulfone bone clamps, and a ﬂexible, autoclav-
able polypropylene enclosure was placed around the joint
and sealed tightly around the bone clamps to maintain
a closed, sterile environment for the joint. Tygon tubing
(Cole Parmer) connected the bioreactor environment to
a reservoir containing 2 l of culture medium (low-glucose
Dulbecco’s modiﬁed Eagle’s medium (DMEM), 10 mM
HEPES buffer, 0.1 mM non-essential amino acids, 0.4 mM
L-proline, 2 mM L-glutamine, 100 units/ml penicillin,
100 mg/ml streptomycin, and 0.25 mg/ml amphotericin B)
supplemented with 5% fetal bovine serum (FBS) and
25 mg/ml ascorbate. The bioreactor was ﬁlled with medium
from the reservoir using a three channel high-ﬂow rate peri-
staltic pump (Wiz Model HF, Teledyne Isco Inc.), operating
at 83 ml/min, which also maintained medium circulation be-
tween the reservoir and the bioreactor throughout the dura-
tion of joint culture. The medium reservoir was submerged
in a water bath to maintain the bioreactor temperature at
37C and humidiﬁed 95% air/5% CO2 was pumped through
a 0.22 mm sterile ﬁlter into the reservoir to maintain the me-
dium at pH 7.4. The bioreactor was adapted for attachment
to a CPM device (FlexMate K500, BREG, Inc.), which can
apply joint motion ranging between 10 and 120 of ﬂex-
ion, at rates between 30/min and 150/min.
For the experiments described here, CPM stimulation
consisted of 24 h of continuous motion, with the joint oscil-
lating between 10 and 46 of ﬂexion [Fig. 1(C)] at 110/min
(43 s per cycle, or w0.025 Hz). Intrinsic tension in the four
intact ligaments maintained the articulating surfaces of the
joint in contact, and no additional axial load was applied.
Since the patella was discarded during dissection, cartilage
from the patellofemoral groove (PFG) was not in direct
contact with other tissues during bioreactor culture with or
without CPM stimulation. In contrast, certain regions of
the lateral and medial femoral condyles (LFC and MFC)
568 G. E. Nugent-Derfus et al.: CPM stimulation of PRG4Fig. 1. CPM bioreactor system for whole joints. (A) Schematic of system for maintaining tissue-culture conditions during CPM stimulation of the
joint. (B) Actual joint in bioreactor. (C) During motion stimulation, the joint oscillates between 10 and 46 of ﬂexion, such that certain regions of
the femoral condyles (D) are continuously (con), intermittently (int), or never (nev) sliding against opposing tissues during stimulation.slide against the adjacent menisci and tibial plateau carti-
lage during CPM stimulation. Thus cartilage from the PFG
was in a similar mechanical environment for joints in both
bioreactor cultures, with or without CPM, and metabolism
of chondrocytes in this region was expected to be indepen-
dent of CPM stimulation. Cartilage from the LFC and MFC
of the joints cultured with CPM was compared to cartilage
from those regions of joints cultured without CPM to deter-
mine direct effects of rehabilitative motion on chondrocyte
health. The LFC and MFC were further divided into three
sub-regions based on the type of contact the sub-region
had with adjacent tibial cartilage and meniscus during the
motion protocol. These sub-regions were designated as
continuously, intermittently, or never sliding against the
adjacent tissues, determined for each joint by visually deter-
mining contact areas at maximum and minimum applied
ﬂexion angles, and this effect is referred to herein as sliding
duty cycle [Fig. 1(D)].
EXPERIMENTAL DESIGN (FIG. 2)
Experiment I: Fresh Joints
Some joints were used to determine the intrinsic level of
PRG4 secretion without bioreactor culture. Following isola-
tion of these joints (n¼ 4, from different animals), cylindrical
cartilage disks (3 mm diameter, w0.5 mm thick) were
explanted from 12, 29, and 36 sites on the PFG, LFC,
and MFC, respectively [sites shown in Fig. 3(B)], and cul-
tured for 2 days in 48-well tissue culture plates and incuba-
tors. Medium (as described above, but with 10% FBS,
0.5 ml per disk) was collected and replaced daily for analy-
sis of PRG4 secretion. Control studies in which cartilage
disks from these locations were cultured for 4 days showed
that the site-associated pattern in PRG4 secretion (relative
secretion among sites) was somewhat variable during day
1, but similar during each of the subsequent 3 days in
culture; thus disks were cultured for 2 days to determine
differences in secretion values among explant sites. For
this reason PRG4 secretion over the ﬁrst 2 days of culture
is presented here for comparison of results of Experiment
I with those of Experiment II.Experiment II: Bioreactor-Cultured Joints
Paired stiﬂe joints from each of four animals were isolated
as described above, and transferred to bioreactors for whole
joints. One bioreactor was attached to the CPM device, while
the other was placed on a bench-top for culture without me-
chanical stimulation. Following 24 h of joint culture in bioreac-
tors, cartilage disks were explanted using aseptic technique
from 24 sites on the PFG, and 30 sites each on the LFC and
MFC [some sites shown in Fig. 3(C)]. Sites on the femoral
condyles were chosen to represent the three sliding duty
cycle conditions [continuously, intermittently, and never slid-
ing against another tissue, Fig. 3(A)]. Each cartilage disk was
Fig. 2. Bovine stiﬂe joints were isolated, dissected, and used in one
of two separate experiments. (Experiment I) Cylindrical cartilage
disks were explanted and cultured for 2 days. (Experiment II) Joints
were cultured for 24 h in the bioreactor with or without CPM
stimulation, and cartilage disks were then explanted and analyzed
for chondrocyte viability or chondrocyte PRG4 expression, or
cultured for 2 days. PRG4 secreted by cartilage explants during
culture was quantiﬁed and characterized from the conditioned
medium samples.
569Osteoarthritis and Cartilage Vol. 15, No. 5Fig. 3. (A) Cartilage disks were explanted from various sites on the PFG and LFC, MFC, and grouped into sub-regions that continuously (con),
intermittently (int), or never (nev) slide against opposing tissues during CPM stimulation. PRG4 secretion by cartilage disks from freshly
isolated (B, Experiment I) or bioreactor-cultured (C, Experiment II, with or without CPM stimulation) joints, represented as a logarithmic color
scale contour mapping of mean secretion values onto the joint regions. Explant sites are shown as open dots.analyzed for PRG4 immunolocalization within chondrocytes
(four disks per region) or PRG4 secretion during 2 days of




The presence of PRG4 within chondrocytes was deter-
mined qualitatively from cartilage disks that were incubated
for 4 h following bioreactor culture in medium supplemented
with 1 mM monensin, essentially as described previously;
such treatment with monensin blocks PRG4 secretion and
thereby enhances the detection of cells expressing PRG4
at high levels during the 4 h time period26. Upon termination
of culture, the disks were frozen in Tissue Tek OCT (Sakura
USA) and sectioned (5 mm slices) perpendicular to the artic-
ular surface. The sections were reacted with mAb 3-A-4
(a generous gift from Dr Bruce Caterson, University of Wales,
Cardiff, UK11), and detected with a peroxidase-based sys-
tem (Vector Labs). Stained samples were viewed to identify
immunoreactive cells, indicating synthesis of PRG4.
Adjacent sections probed with a non-speciﬁc mouse IgG
antibody served as negative controls. Qualitative results
were documented by photomicroscopy using brightﬁeld
illumination.
PRG4 Secretion
Culture medium was collected and replaced every 24 h
for cartilage disks incubated for 2 days. As described previ-
ously26, conditioned medium samples were quantitatively
analyzed for PRG4 content by indirect ELISA using mAb
3-A-4. Brieﬂy, samples were diluted serially, adsorbed,
and then reacted with mAb 3-A-4, horseradish peroxi-
dase-conjugated secondary antibody, and ABTS substrate,
with three washes with PBSe0.1% Tween (Bio-Rad) be-
tween each step. A standard curve was generated fromsamples containing known amounts of PRG4, obtained
from conditioned medium from explants from the superﬁcial
zone of bovine calf cartilage as previously described1. The
protein-equivalent amount of PRG4 in each sample was
calculated from the linear region of the standard curve (be-
tween 0.078 and 5 mg/ml of PRG4), as described previ-
ously26,27. Control studies indicated that cartilage disks
contained PRG4 in amounts, w1 mg/cm2, that were small
relative to that secreted into the medium, so that the se-
creted quantities were representative of biosynthesis levels.
Control studies showed that cartilage viability, assessedby
staining cartilage disks with Calcein-AM and ethidium homo-
dimer-1 to localize live and dead cells, respectively, and
quantiﬁed by image analysis with Matlab, was maintained
during bioreactor culture, with or without CPM stimulation.
Chondrocyte viability was high (80e93%) for all regions
and loadingconditions, andvariedsomewhatwith joint region
(P¼ 0.07), but not in a CPM-dependentmanner (P¼ 0.42 for
interaction between CPM stimulation and joint region).
DATA REDUCTION
PRG4 Immunolocalization
Chondrocytes staining for PRG4 (PRG4þ) as well as
those not expressing PRG4 (PRG4) were identiﬁed
manually in a 300 mm 400 mm area of each vertical sec-
tion (one randomly chosen section from central region of
each cartilage disk), and counted by image analysis with
Matlab 7.0. Since the total number of cells varied with joint
region, PRG4 expression was reported as a percentage of
the total cell number in the area counted: % PRG4þ¼
(100% #PRG4þ chondrocytes)/(#PRG4þ chondrocytesþ #
PRG4e chondrocytes).
PRG4 Secretion
PRG4 protein secretion was reported normalized to
cartilage disk surface area, and was also represented as
570 G. E. Nugent-Derfus et al.: CPM stimulation of PRG4a contour plot. The contour plot was created using Matlab
7.0 to interpolate between input mean secretion values at
the locations of each cartilage disk, and mapped onto the
joint surface, with color indicating the level of secretion by
the cartilage disk taken from that location, on a logarithmic
scale.
STATISTICAL ANALYSIS
All data are expressed as the mean standard error of
the mean (S.E.M.). Statistical analyses were performed using
Systat 10.2 software.
Experiment I
PRG4 secretion values were log transformed for normal-
ity, and effects of joint region (PFG, LFC, MFC) and site
[indicated by dots, Fig. 3(B)] on PRG4 secretion by cartilage
explants from freshly harvested joints were determined by
repeated measures ANOVA (region and site as repeated
factors) and post-hoc comparisons for the interaction
between region and site.
Experiment II
PRG4 Expression: Percentage data were arcsine trans-
formed, and effects of CPM and duty cycle were determined
by ANOVA with Tukey post-hoc tests.
PRG4 Secretion: Secretion values were log transformed
and effects of CPM and joint region were determined by
repeated measures ANOVA.
Results
EXPERIMENT I (FIG. 2): FRESH JOINTS
Intrinsic chondrocyte PRG4 secretion, determined from
freshly isolated joints, was highly dependent on cartilage
location [Fig. 3(B)]. PRG4 secretion from cartilage disks
varied markedly with explant site (indicated by dots,
Fig. 3) within the LFC (P< 0.01) and MFC (P< 0.001) re-
gions, but not within the PFG region (P¼ 0.78). Averaging
secretion values over all sites within a given region sug-
gested (P¼ 0.1) that in general, cartilage from the PFG
and MFC secreted similar amounts of PRG4 on average
(55 18, 42 7 mg/(cm2day), respectively), while carti-
lage from the LFC secreted only 27 5 mg/(cm2day).
Finally, PRG4 secretion rates varied strikingly among the
four animals, with the coefﬁcient of variation (CV) of
PRG4 secretion values at a given cartilage explant site
ranging from 13 to 158%.
EXPERIMENT II (FIG. 2): BIOREACTOR-CULTURED JOINTS
CPM stimulation up-regulated PRG4 biosynthesis in
cartilage from certain locations of the joint. PRG4 immuno-
localization [Figs. 4(A) and 5] revealed that the percent of
the chondrocyte population expressing PRG4 was regu-
lated by CPM in a sliding duty cycle dependent manner
(P< 0.001 for interaction between CPM and sliding duty
cycle). The regions of the femoral condyles that were
continuously sliding against cartilage/meniscus in the joint
cultured with CPM [Fig. 5(I,L)] contained more PRG4þ
chondrocytes (LFC: 37 4%, P< 0.001; MFC: 40 5%,
P< 0.01), compared to the same regions of the joint
cultured without CPM [Fig. 5(B,E)], where 13 3% and22 2% of chondrocytes expressed PRG4, respectively,
in the LFC and MFC. In addition, cartilage from the region
of the LFC that was intermittently sliding against cartilage/
meniscus [Fig. 5(C,J)] had higher PRG4 expression
(P< 0.01) with CPM (36 8%) than without (13 4%),
though an effect of CPM was not detected for the intermit-
tently sliding region of the MFC [P¼ 0.99, Fig. 5(F,M)],
where 37 5% of chondrocytes were PRG4þ. As ex-
pected, PRG4 expression was independent of CPM for
the PFG region [52 2%, P¼ 0.99, Fig. 5(A,H)] and for
regions of the LFC (43 1%, P¼ 1.0) and MFC (40 5%,
P¼ 1.0) that were never sliding against cartilage/meniscus
during CPM [Fig. 5(D,K,G,N)].
Bioreactor culture with CPM appeared to also maintain
chondrocyte PRG4 secretion in a sliding duty cycle depen-
dent manner [duty cycle regions shown in Fig. 3(A)],
compared to bioreactor culture without joint motion [Figs.
3(C) and 4(B)]. Consistent with effects on PRG4 expres-
sion, PRG4 secretion in continuously sliding regions of
the LFC tended to be higher (P¼ 0.2) in cartilage from the
CPM stimulated joint [11 5 mg/(cm2day)] than in carti-
lage from the same region of the joint cultured without
CPM [4 2 mg/(cm2day)]. Averaged over all sites in
a given region, PRG4 secretion also varied with joint region
(P< 0.05), consistent with the trend for cartilage from
freshly isolated joints (Experiment I). The PFG and MFC
secreted more PRG4 [40 7 and 27 8 mg/(cm2day), re-
spectively, P< 0.05 each] than cartilage from the LFC
[10 2 mg/(cm2day)]. Cartilage from the PFG regions of
joints cultured both with CPM and without CPM secreted
similar amounts of PRG4 (P> 0.9). As expected, CPM stim-
ulation did not affect PRG4 secretion by cartilage from sub-
regions of the LFC [12 5 mg/(cm2day), P¼ 1.0] and MFC
[12 4 mg/(cm2day), P¼ 0.56] that were never sliding
against cartilage/meniscus during CPM stimulation. Secre-
tion values were also unaffected by CPM in regions of inter-
mittent sliding [LFC: 14 5 mg/(cm2day); MFC: 27 10
mg/(cm2day), P> 0.9 each].
Discussion
These results identify a mechanism by which joint motion
and CPM may contribute to maintenance of joint health, and
demonstrate the ability to culture whole joints in a bioreactor.
CPM increased the percentage of chondrocytes expressing
PRG4 [Figs. 4(A) and 5(B,E,I,L)] and tended to increase
PRG4 secretion [Figs. 3(C) and 4(B)] for cartilage in the
regions of the femoral condyles that were continuously slid-
ing against adjacent meniscus/cartilage, compared to those
values for the corresponding regions of joints cultured with-
out CPM. Intermittent sliding against adjacent meniscus/
cartilage was also sufﬁcient to up-regulate chondrocyte
PRG4 expression in cartilage from the LFC [Figs. 4(A)
and 5(C,J)]. Chondrocyte viability remained high during bio-
reactor culture of joints and was independent of applied
CPM, suggesting that differences in PRG4 metabolism
were due to mechanical regulation in certain regions, rather
than cell death. In addition, the marked site-associated
variation in intrinsic chondrocyte PRG4 secretion over the
joint surface was revealed [Fig. 3(B)].
The parameters of rehabilitative joint motion, applied
through CPM, were chosen based on previous protocols
found to be stimulatory, and also consideration of knee joint
kinematics. For example, the cycling frequency (43 s per
cycle) is similar to that found most effective in healing carti-
lage defects in rabbits28, and is in the range of frequencies
571Osteoarthritis and Cartilage Vol. 15, No. 5Fig. 4. (A) Chondrocyte PRG4 expression in cartilage sections, and (B) PRG4 secretion of cartilage disks from the PFG and various sub-
regions (based on sliding duty cycle) of the LFC, MFC of bovine stiﬂe joints after culture in a whole joint bioreactor with (-) or without
(,) CPM stimulation. Mean S.E.M. n¼ 3e4 animals. *P< 0.01, **P< 0.001.typically used for in vitro experimentation with CPM
(40e45 s per cycle21,29,30). The range of motion used
here was within the range of ﬂexion angles typically experi-
enced during walking (0e41 minimum to 50e77 maxi-
mum ﬂexion angle) for both human knee joints31,32 and
ovine stiﬂe joints33. This study did not attempt to reproduce
joint muscle forces, which also contribute to normal active
and passive loading of the joint (total joint compressive
forces up to three times body weight34). Axial loading in
the present experiments was due to forces in the intact cru-
ciate and collateral ligaments35. Thus the loading applied
here is more similar in nature to that applied during CPM re-
habilitative therapies than to that experienced during daily
activities. The study of physiological levels of axial com-
pression in addition to the CPM stimulation protocol could
provide additional insight into the biomechanical regulation
of chondrocyte metabolism in vivo.
Also, since the goal of this study was to determine, in
a controlled manner, the effects of CPM on chondrocyte
metabolism, several joint tissues were removed. While pa-
tellofemoral joint forces contribute to the kinematics of
knee motion in vivo36e38, removal of the patella allowed
for an internal control region (i.e., PFG) of cartilage that ex-
perienced the same mechanical environment in joints cul-
tured both with and without CPM. Synovial ﬂuid was also
removed, and the medium used to bathe the joint was
a baseline formulation typically used for cartilage and chon-
drocyte cultures, different in composition from the synovial
ﬂuid that normally bathes cartilage in vivo. This created
a well-deﬁned biochemical environment that allowed effects
of CPM itself to be determined. Fetal bovine serum was
added during bioreactor culture, as it has been shown tomaintain cartilage proteoglycan synthesis in vitro39. Speciﬁc
chemokines and growth factors could also be added during
bioreactor culture, without CPM to assess the effects of bio-
chemical stimuli on chondrocytes in intact cartilage, or with
CPM to investigate possible interactive effects of biome-
chanical and biochemical stimuli.
While many factors are important to the maintenance of
joint health, PRG4 metabolism was chosen for study be-
cause it is a functional lubricant whose expression is me-
chanosensitive. First, since PRG4 molecules function to
provide boundary lubrication during cartilage-on-cartilage
sliding7, it was hypothesized that mechanical conditions
that require lubrication (cartilage sliding against cartilage
and meniscus in a physiological conﬁguration) might result
in increased PRG4 production. Furthermore, chondrocyte
PRG4 metabolism is markedly regulated by micro-environ-
mental cues during short-term culture, including both bio-
chemical40,41 and biomechanical15,16 stimuli, such that
effects of rehabilitative joint motion were likely to be de-
tected. PRG4 expression (by immunolocalization) provided
a snapshot of chondrocyte populations expressing PRG4
immediately (during the 4 h monensin treatment period)
upon termination of CPM, while PRG4 secretion provided
a functional measure of lubricant production over 2 days fol-
lowing bioreactor culture. The difference in timing between
these measures of PRG4 biosynthesis, as well as the differ-
ence in quantity being measured (cells expressing PRG4 vs
amount of PRG4 secreted) could account for the differ-
ences between effects of loading on PRG4 secretion and
on PRG4 expression, for example, in the case of the inter-
mittently stimulated region of the LFC [Figs. 4(A,B) and
5(C,J)]. The immunolocalization analysis of PRG4 may be
572 G. E. Nugent-Derfus et al.: CPM stimulation of PRG4expected to be more sensitive to loading than the secretion
analysis, since the effects of certain types of load on PRG4
secretion are diminished within the days following termina-
tion of applied load15,16. The marked intrinsic topographical
variation in these measures may be due to the high
mechano-sensitivity of chondrocyte expression of PRG4,
combined with wide variations in biomechanical environ-
ments experienced by different joint regions. The high
inter-animal variation could account for the slightly lower
overall PRG4 secretion levels in the bioreactor-cultured
joints compared to the levels secreted by freshly harvested
joints, which were from different animals. However, the use
of animal-matched joints (right and left from the same ani-
mal) for each run of Experiment II eliminated this issue for
comparison of joints cultured in bioreactors with and without
CPM. Alternatively, the lower overall PRG4 secretion from
bioreactor-cultured tissue could be due to the equilibration
of the cartilage in culture medium for 24 h (during bioreactor
culture) prior to explant culture.
The novel bioreactor for CPM stimulation of whole joints
developed in this study provided the means to investigate
mechano-regulation of PRG4 metabolism in a loading envi-
ronment that is more physiological than that of traditional
bioreactor culture systems, while at the same time eliminat-
ing some of the confounding factors present with in vivo
studies. The marked site-associated variation in chondro-
cyte PRG4 secretion and expression and the apparent de-
pendence on local mechanical environment, taken together
with the altered PRG4 expression patterns seen in tibial
cartilage subjected to abnormal mechanical stimulation12,
further support the hypothesis that mechanical factors are
key determinants of PRG4 metabolism in vivo. CPM stimu-
lation resulted in up-regulation of PRG4 secretion and
expression levels by nearly 3-fold in the continuously
stimulated region of the LFC, consistent with the 3-fold in-
crease in proteoglycan production resulting from tissue
shear of cylindrical cartilage explants16, and the 3e7-fold
up-regulation of PRG4 mRNA due to surface motion applied
to chondrocytes in cartilaginous constructs13. These results
also raise the possibility that regulation of PRG4 metabo-
lism may depend on loading duty cycle, as intermittent
cartilage sliding was sufﬁcient to alter PRG4 expression in
the LFC, though this did not occur in the MFC. Since
intermittent sliding did not appear sufﬁcient to alter chondro-
cyte secretion of PRG4 in either femoral condyle, it may be
that intermittent sliding led to transient up-regulation,
whereas continuous sliding resulted in longer-lasting
effects.
The ﬁnding that CPM during culture maintains chondro-
cyte viability and metabolic function supports the use of
CPM, instead of immobilization, as a post-operative treat-
ment, and may indicate a mechanism by which CPM is
beneﬁcial to the health of cartilage and joints in vivo. In ad-
dition, PRG4 synthesis was very low in cartilage from
certain regions of the joint cultured without CPM, consistent
with previous reports that joint immobilization causes de-
creased chondrocyte metabolism of matrix molecules,
which results in decreased cartilage thickness and mechan-
ical integrity42e45. Thus, these results suggest that the
negative effects of immobilization may also be due to
Fig. 5. Immunolocalization of PRG4 (dark purple stain) within chon-
drocytes. Shown are representative images of cartilage samples
from various joint regions, after bioreactor culture without (CPM,
AeG), or with CPM stimulation (þCPM, HeN). Bar¼ 100 mm.
573Osteoarthritis and Cartilage Vol. 15, No. 5down-regulation of chondrocyte synthesis of lubricant and
chondroprotective PRG4 molecules.
The higher up-regulation of PRG4 secretion and expres-
sion in the LFC (3-fold for both measures) compared to the
MFC (1.5-fold for secretion,w1.8-fold for expression) in the
continuously sliding region, as well as the ability of intermit-
tent sliding to up-regulate PRG4 expression in the LFC but
not the MFC, could be due to differences in biomechanical
environment experienced by the two regions during CPM. In
humans, the LFC and MFC experience distinct motion pat-
terns relative to the adjacent tissues during knee ﬂexion,
with the MFC tending to move by sliding against the tibial
plateau, while the LFC tends to ‘‘roll’’ across the tibial pla-
teau46e48. This may also be the case for the bovine stiﬂe
joint, although with anatomically opposite tendencies (LFC
sliding, MFC rolling), as the relative size and shape of the
bovine femoral condyles and PFG are opposite to that of
humans. These observations suggest that sliding, which
would impart shearing deformation to the tissue, leads to
more up-regulation of PRG4 secretion than rolling, which
would sequentially impart compressive deformation to
different sites. Alternatively, the up-regulation of PRG4
expression and secretion in certain regions could be due
to increased nutrient transport to those regions resulting
from motion of the joint (compared to the transport level
during bioreactor culture without motion), the unique joint
loading patterns applied during CPM, or regional differ-
ences in cell phenotype.
The CPM bioreactor for whole joints developed in this
study provides a platform for possible future in vitro studies
and applications, including the assessment of the effects of
CPM on metabolism of various joint tissues and possible
interactions of biomechanical and biochemical signals.
This system could also be used to investigate the effects
of rehabilitative joint motion on the efﬁcacy of various carti-
lage defect repair strategies in live tissue in vitro, as
described for postmortem tissue49, before moving on to
more costly and complicated in vivo studies50. The current
system allows for the simultaneous culture of two joints,
but could be scaled up for culture of many joints in parallel.
In addition, this bioreactor may be useful for in vitro culture
of biological joints which could ultimately be used as restor-
ative implants for large cartilage defects, and possibly
whole joints.
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